vs
FLEXSTEEL INDUSTRIES INC（FLXS）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是FLEXSTEEL INDUSTRIES INC的1.8倍（$207.3M vs $115.1M），FLEXSTEEL INDUSTRIES INC净利率更高（17.7% vs -62.0%，领先79.8%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs -64.7%），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 1.9%）
Flexsteel Industries Inc是一家总部位于美国的家具制造商，设计、生产并销售各类软垫住宅家具、商用家具及酒店家具，主要面向北美市场运营，通过广泛的分销网络服务终端消费者、零售合作伙伴及企业客户。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
FLXS vs RARE — 直观对比
损益表 — Q1 FY2027 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $115.1M | $207.3M |
| 净利润 | $20.4M | $-128.6M |
| 毛利率 | 22.6% | — |
| 营业利润率 | — | -54.7% |
| 净利率 | 17.7% | -62.0% |
| 营收同比 | -64.7% | 25.9% |
| 净利润同比 | 116.0% | 3.5% |
| 每股收益（稀释后） | $1.14 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q3 26 | $115.1M | — | ||
| Q4 25 | $118.2M | $207.3M | ||
| Q3 25 | $110.4M | $159.9M | ||
| Q2 25 | $114.6M | $166.5M | ||
| Q1 25 | $114.0M | $139.3M | ||
| Q4 24 | $108.5M | $164.6M | ||
| Q3 24 | $104.0M | $139.5M | ||
| Q2 24 | $110.8M | $147.0M |
| Q3 26 | $20.4M | — | ||
| Q4 25 | $6.6M | $-128.6M | ||
| Q3 25 | $7.3M | $-180.4M | ||
| Q2 25 | $10.7M | $-115.0M | ||
| Q1 25 | $-3.7M | $-151.1M | ||
| Q4 24 | $9.1M | $-133.2M | ||
| Q3 24 | $4.1M | $-133.5M | ||
| Q2 24 | $4.9M | $-131.6M |
| Q3 26 | 22.6% | — | ||
| Q4 25 | 22.7% | — | ||
| Q3 25 | 23.5% | — | ||
| Q2 25 | 23.9% | — | ||
| Q1 25 | 22.2% | — | ||
| Q4 24 | 21.0% | — | ||
| Q3 24 | 21.5% | — | ||
| Q2 24 | 21.3% | — |
| Q3 26 | — | — | ||
| Q4 25 | 7.6% | -54.7% | ||
| Q3 25 | 8.1% | -106.9% | ||
| Q2 25 | 12.2% | -64.8% | ||
| Q1 25 | -4.4% | -102.6% | ||
| Q4 24 | 10.7% | -74.3% | ||
| Q3 24 | 5.8% | -94.6% | ||
| Q2 24 | 6.9% | -79.1% |
| Q3 26 | 17.7% | — | ||
| Q4 25 | 5.6% | -62.0% | ||
| Q3 25 | 6.6% | -112.8% | ||
| Q2 25 | 9.3% | -69.0% | ||
| Q1 25 | -3.3% | -108.5% | ||
| Q4 24 | 8.3% | -80.9% | ||
| Q3 24 | 4.0% | -95.7% | ||
| Q2 24 | 4.4% | -89.5% |
| Q3 26 | $1.14 | — | ||
| Q4 25 | $1.18 | $-1.28 | ||
| Q3 25 | $1.31 | $-1.81 | ||
| Q2 25 | $1.90 | $-1.17 | ||
| Q1 25 | $-0.71 | $-1.57 | ||
| Q4 24 | $1.62 | $-1.34 | ||
| Q3 24 | $0.74 | $-1.40 | ||
| Q2 24 | $0.87 | $-1.52 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $57.3M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $185.3M | $-80.0M |
| 总资产 | $290.2M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q3 26 | $57.3M | — | ||
| Q4 25 | $36.8M | $421.0M | ||
| Q3 25 | $38.6M | $202.5M | ||
| Q2 25 | $40.0M | $176.3M | ||
| Q1 25 | $22.6M | $127.1M | ||
| Q4 24 | $11.8M | $174.0M | ||
| Q3 24 | $5.7M | $150.6M | ||
| Q2 24 | $4.8M | $480.7M |
| Q3 26 | $185.3M | — | ||
| Q4 25 | $178.9M | $-80.0M | ||
| Q3 25 | $172.2M | $9.2M | ||
| Q2 25 | $167.9M | $151.3M | ||
| Q1 25 | $158.1M | $144.2M | ||
| Q4 24 | $161.9M | $255.0M | ||
| Q3 24 | $154.7M | $346.8M | ||
| Q2 24 | $150.4M | $432.4M |
| Q3 26 | $290.2M | — | ||
| Q4 25 | $290.2M | $1.5B | ||
| Q3 25 | $281.5M | $1.2B | ||
| Q2 25 | $282.5M | $1.3B | ||
| Q1 25 | $266.1M | $1.3B | ||
| Q4 24 | $271.5M | $1.5B | ||
| Q3 24 | $268.7M | $1.5B | ||
| Q2 24 | $274.5M | $1.6B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.2M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-100.8M |
| 自由现金流率自由现金流/营收 | — | -48.6% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | 1.33× | — |
| 过去12个月自由现金流最近4个季度 | — | $-472.0M |
8季度趋势，按日历期对齐
| Q3 26 | $27.2M | — | ||
| Q4 25 | $1.0M | $-99.8M | ||
| Q3 25 | $4.1M | $-91.4M | ||
| Q2 25 | $15.6M | $-108.3M | ||
| Q1 25 | $12.3M | $-166.5M | ||
| Q4 24 | $6.7M | $-79.3M | ||
| Q3 24 | $2.4M | $-67.0M | ||
| Q2 24 | $7.5M | $-77.0M |
| Q3 26 | — | — | ||
| Q4 25 | $-735.0K | $-100.8M | ||
| Q3 25 | $2.8M | $-92.7M | ||
| Q2 25 | $15.1M | $-110.7M | ||
| Q1 25 | $10.9M | $-167.8M | ||
| Q4 24 | $5.8M | $-79.5M | ||
| Q3 24 | $2.0M | $-68.6M | ||
| Q2 24 | $7.1M | $-79.0M |
| Q3 26 | — | — | ||
| Q4 25 | -0.6% | -48.6% | ||
| Q3 25 | 2.5% | -58.0% | ||
| Q2 25 | 13.1% | -66.5% | ||
| Q1 25 | 9.6% | -120.5% | ||
| Q4 24 | 5.3% | -48.3% | ||
| Q3 24 | 1.9% | -49.2% | ||
| Q2 24 | 6.4% | -53.7% |
| Q3 26 | — | — | ||
| Q4 25 | 1.5% | 0.5% | ||
| Q3 25 | 1.2% | 0.8% | ||
| Q2 25 | 0.5% | 1.5% | ||
| Q1 25 | 1.2% | 1.0% | ||
| Q4 24 | 0.8% | 0.1% | ||
| Q3 24 | 0.4% | 1.2% | ||
| Q2 24 | 0.4% | 1.4% |
| Q3 26 | 1.33× | — | ||
| Q4 25 | 0.15× | — | ||
| Q3 25 | 0.56× | — | ||
| Q2 25 | 1.46× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 0.58× | — | ||
| Q2 24 | 1.53× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FLXS
暂无分部数据
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
